Roche

Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds
BioSpace
Wed, 04/24/24 - 09:55 am
Roche
Genentech
earnings
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche
Fierce Pharma
Wed, 04/24/24 - 08:50 am
orphan drugs
Evaluate Pharma
JNJ
Vertex Pharmaceuticals
Roche
Roche wins FDA OK for targeted drug in early lung cancer
BioPharma Dive
Fri, 04/19/24 - 11:40 am
Roche
Alecensa
ALK inhibitors
FDA
non-small cell lung cancer
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
Xtalks
Thu, 04/18/24 - 10:28 pm
Roche
FDA
Medtech
Eli Lilly
Elecsys pTau217
Alzheimer's disease
diagnostics
Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Fierce Pharma
Wed, 04/17/24 - 11:33 am
Roche
Ocrevus
MS
multiple sclerosis
AAN
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
Fierce Biotech
Wed, 04/17/24 - 11:20 am
Pfizer
R&D
Roche
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Clinical Trials Arena
Mon, 04/15/24 - 11:07 am
Roche
clinical trials
Columvi
DLBCL
Roche, Adaptimmune part ways on cell therapy research
BioPharma Dive
Sun, 04/14/24 - 01:26 pm
Roche
Genentech
cell therapy
cancer
Adaptimmune
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thu, 04/11/24 - 10:52 am
diagnostics
Roche
Eli Lilly
Alzheimer's disease
FDA
breakthrough designation
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Roche autoimmune disease drug disappoints in closely watched trial
BioPharma Dive
Thu, 03/21/24 - 06:36 pm
Roche
Chugai
clinical trials
myasthenia gravis
Enspryng
Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028
Biopharma Reporter
Thu, 03/21/24 - 11:37 am
Pfizer
Braftovi
Roche
Zelboraf
melanoma
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche
BioSpace
Wed, 03/20/24 - 11:51 am
Bristol Myers Squibb
immuno-oncology
Opdivo
Yervoy
liver cancer
AstraZeneca
Roche
Lonza adds biologics capacity with $1.2bn Roche deal
Pharmaphorum
Wed, 03/20/24 - 11:17 am
Roche
Lonza
drug manufacturing
Switzerland
CDMOs
Roche Plots Neuro Comeback with Promising Mid-Stage Alzheimer’s Data
BioSpace
Tue, 03/12/24 - 11:14 am
Roche
Alzheimer's disease
monoclonal antibodies
Roche to take on Abbott, Dexcom with its first CGM
Medtech Dive
Fri, 03/8/24 - 11:13 am
Medtech
Roche
CGMs
diabetes
Abbott Labs
DexCom
Accu-Chek Smartguide
Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage
Forbes
Wed, 03/6/24 - 11:25 am
Roche
Novartis
Xolair
insurers
food allergies
Roche, Alnylam say blood pressure drug succeeds in mid-stage trial
Reuters
Tue, 03/5/24 - 11:07 am
Roche
Alnylam Pharmaceuticals
clinical trials
hypertension
zilebesiran
Roche Reassesses Esbriet's Future Amidst Generic Drug Competition
Medriva
Tue, 02/27/24 - 11:28 am
Roche
generics
Esbriet
IPF
Roche evaluates options for its lung disease drug
Reuters
Mon, 02/26/24 - 05:12 pm
Roche
Esbriet
lung cancer

Pages